What Is Renal Osteodystrophy and How Does It Affect Bone Health?

Kidneys do more than remove waste from the blood. They also help regulate calcium, phosphorus and vitamin D, which are essential for maintaining healthy bones. As kidney function declines, these processes can become disrupted, leading to problems with mineral balance and bone health. 

This broader condition is known as CKD mineral bone disorder (CKD-MBD), while the changes that occur specifically in the bones are called renal osteodystrophy.

What Is Renal Osteodystrophy? 

Renal osteodystrophy is defined as aberrant changes in bone structure and turnover, which occur because of chronic renal disease. It occurs when impaired kidney function upsets the usual balance of minerals and hormones that support bone growth and renewal.

This condition is part of the broader kidney disease and bone health relationship and becomes more common as CKD advances, particularly in those with kidney failure on dialysis.

How CKD Disrupts Calcium and Phosphorus Balance

Healthy kidneys eliminate excess phosphorus from the blood and convert vitamin D to its active form, calcitriol. This active vitamin D helps the body absorb calcium from meals. As kidney function declines, the kidneys eliminate less phosphorus and produce less active vitamin D. These alterations may reduce calcium availability and raise parathyroid hormone (PTH).

Over time, this imbalance can affect how quickly bone tissue breaks down and rebuilds. That’s one key reason kidney disease and bone health are so closely intertwined.

The Bone-Kidney Connection

We continually replace our bones, old bone is removed and new bone is laid down. Calcium, phosphorus, vitamin D and PTH are all part of this process. CKD can impact their equilibrium and bones can become weaker, softer or more fragile.

This situation means renal osteodystrophy is not simply a problem caused by low calcium. Several minerals and hormones can be involved and their levels must be considered together when managing CKD mineral bone disorder.

The Role of Parathyroid Hormone (PTH) in Bone Damage

When kidney function decreases, phosphorus may accumulate and active vitamin D may decrease. The parathyroid glands may respond by producing extra PTH to maintain normal blood calcium levels. PTH can leach calcium from the bones and chronically elevated levels can lead to increased turnover and compromised bone structure.

This process is known as secondary hyperparathyroidism and is an important part of CKD mineral bone disorder. Monitoring PTH along with calcium, phosphorus and alkaline phosphatase can help doctors assess changes in bone and mineral metabolism.

Types of Renal Osteodystrophy

The pattern of bone changes can differ from one person to another. The main types include:

High-Turnover Bone Disease

High-turnover bone disease occurs when bone is being broken down and rebuilt too quickly, often because PTH levels remain high. Osteitis fibrosa is a common form associated with secondary hyperparathyroidism.

Low-Turnover (Adynamic) Bone Disease

In a dynamic bone disease, bone turnover becomes unusually low. This means the normal process of removing old bone and forming new bone is reduced. It can occur when PTH is suppressed too much, particularly in people receiving treatment for CKD-MBD.

Mixed Uremic Osteodystrophy

Some patients can have features of both high and low bone turnover along with problems affecting bone mineralisation. This mixed pattern can complicate assessment and treatment.

Common Symptoms: Bone Pain, Fractures and Deformities

Bone changes can develop gradually and many people may not notice symptoms in the early stages. When symptoms do occur, they can include:

• Bone or joint pain
• Weakness or muscle cramps
• Bones that fracture more easily
• Changes in bone structure or deformities
• Difficulty with movement because of pain or weakness

Bone pain and kidney disease can be difficult to identify because pain may have many other causes. A person should therefore not assume that any new bone or joint pain is caused by renal osteodystrophy.

How Renal Osteodystrophy Is Diagnosed

Doctors generally assess mineral and hormone levels together with a person's CKD history, symptoms and risk of fractures. Because renal osteodystrophy is specifically a bone abnormality, a comprehensive blood test may be required to fully define its type.

Blood Tests (Calcium, Phosphorus, PTH)

Blood tests can measure:

• Calcium
• Phosphorus
• PTH
• Vitamin D, when appropriate
• Alkaline phosphatase

It is recommended to monitor calcium, phosphorus, PTH and alkaline phosphatase as part of CKD-MBD assessment, with the frequency depending on CKD stage and the severity of abnormalities.

Bone Density Scans and X-rays

A bone density scan, such as a DEXA scan, may be recommended when assessing fracture risk if the result is likely to affect treatment. However, these tests do not by themselves identify the specific type of renal osteodystrophy. In selected cases, a bone biopsy may be considered if knowing the type of bone disease would change treatment.

Treatment and Prevention

Treatment focuses on correcting mineral and hormone imbalances while protecting bone and blood vessel health. The approach depends on kidney function, laboratory results, symptoms and whether the person is receiving dialysis.

Diet and Phosphate Binders

Managing phosphorus intake can help control phosphorus levels. People with CKD may be advised to reduce foods high in phosphorus, particularly processed foods containing phosphorus-based additives.

Phosphate binders may also be prescribed. These medicines bind phosphorus from food in the digestive tract, reducing how much enters the bloodstream. They should be taken exactly as prescribed.

Vitamin D and Calcium Management

Vitamin D medicines, calcium supplements or other treatments may be used when appropriate. However, taking calcium or vitamin D without medical advice is not recommended because excessive amounts can also cause problems.

The aim is to maintain appropriate calcium, phosphorus and PTH levels rather than simply increasing one mineral.

Dialysis Adjustments

For individuals on dialysis, the treatment team periodically checks calcium, phosphorus and PTH and may change the dialysis prescription, diet or drugs based on the results. It is also vital to complete scheduled dialysis sessions, as dialysis helps to remove extra waste and phosphorus from the blood.

Conclusion

Chronic kidney illness impairs the processes that maintain healthy bones, leading to the development of renal osteodystrophy. Regular monitoring of calcium, phosphorus and PTH, along with proper diet, medication and dialysis care, can help manage these changes and prevent complications.

NephroPlus provides in-clinic dialysis, home haemodialysis, dialysis on wheels, dialysis on call and holiday dialysis. The right option depends on your medical needs and the plan you have agreed with your nephrology team.

Frequently Asked Questions (FAQ's)

Can renal osteodystrophy be cured?

There is no single cure because renal osteodystrophy is linked to chronic kidney disease and the resulting mineral and hormone changes. However, treatment can help control these abnormalities and reduce further bone damage. Managing phosphorus, calcium and PTH levels, along with appropriate dialysis and prescribed medicines, can help protect bone health.

Is bone pain always a sign of renal osteodystrophy?

No. Bone pain and kidney disease can occur with CKD-MBD, but bone and joint pain can also have many other causes. Persistent or unexplained pain should be discussed with a healthcare professional rather than assumed to be renal osteodystrophy.

How is renal osteodystrophy treated in dialysis patients?

Treatment may include dietary phosphorus management, phosphate binders, vitamin D-related medicines and treatment for abnormal PTH levels. The dialysis team may also adjust treatment based on ongoing blood tests. The exact approach depends on the person's calcium, phosphorus, PTH, kidney function and other health conditions.